tiprankstipranks
Inovio’s INO-3107 shows efficacy in Phase 1/2 RRP trial
PremiumThe FlyInovio’s INO-3107 shows efficacy in Phase 1/2 RRP trial
2M ago
Inovio price target lowered to $15 from $33 at Oppenheimer
Premium
The Fly
Inovio price target lowered to $15 from $33 at Oppenheimer
2M ago
Inovio price target lowered to $5 from $12 at H.C. Wainwright
Premium
The Fly
Inovio price target lowered to $5 from $12 at H.C. Wainwright
2M ago
Inovio reports data from Phase 1/2 trial on INO-3107
PremiumThe FlyInovio reports data from Phase 1/2 trial on INO-3107
2M ago
Options Volatility and Implied Earnings Moves This Week, November 11 – November 15, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, November 11 – November 15, 2024
2M ago
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Options Volatility and Implied Earnings Moves Today, August 08, 2024
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, August 08, 2024
5M ago
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Inovio’s INO-3107 granted Advanced Therapy Medicinal Product Certificate by EMA
Premium
The Fly
Inovio’s INO-3107 granted Advanced Therapy Medicinal Product Certificate by EMA
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100